Accelerated degeneration of a bovine pericardial bioprosthetic aortic valve in children and young adults

Circulation

Volumn 130, Issue 1, 2014, Pages 51-60

  Saleeb, Susan F ^a,b   Newburger, Jane W ^a,b   Geva, Tal ^a,b   Baird, Christopher W ^a,b   Gauvreau, Kimberlee ^a,b   Padera, Robert F ^b,c   Del Nido, Pedro J ^a,b   Borisuk, Michele J ^a,b   Sanders, Stephen P ^a,b   Mayer, John E ^a,b  

^a BOSTON CHILDREN S HOSPITAL   (United States)

^b HARVARD MEDICAL SCHOOL   (United States)

^c BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

Congenital; Heart defects; Prosthesis implantation; Valves

Indexed keywords

ADOLESCENT; ADULT; AORTA STENOSIS; AORTA VALVE PROSTHESIS; AORTA VALVE REGURGITATION; AORTA VALVE REPLACEMENT; ARTICLE; BODY SURFACE; CALCIFICATION; CHILD; CLINICAL ARTICLE; COMPUTER ASSISTED TOMOGRAPHY; ECHOCARDIOGRAPHY; FEMALE; HUMAN; HUMAN TISSUE; HYPOPLASTIC LEFT HEART SYNDROME; INFLAMMATION; MALE; PRIORITY JOURNAL; SCHOOL CHILD; YOUNG ADULT;

HEART DEFECTS, CONGENITAL; PROSTHESIS IMPLANTATION; VALVES;

ADOLESCENT; ADULT; ANIMALS; AORTIC VALVE; AORTIC VALVE STENOSIS; BIOPROSTHESIS; CALCINOSIS; CATTLE; CHILD; DEATH, SUDDEN, CARDIAC; FEMALE; FOLLOW-UP STUDIES; HEART VALVE PROSTHESIS; HEART VALVE PROSTHESIS IMPLANTATION; HUMANS; HYPERTROPHY, LEFT VENTRICULAR; MALE; PERICARDIUM; POSTOPERATIVE COMPLICATIONS; PROSTHESIS FAILURE; RECURRENCE; RETROSPECTIVE STUDIES; RISK; YOUNG ADULT;

EID: 84903781575     PISSN: 00097322     EISSN: 15244539     Source Type: Journal    
DOI: 10.1161/CIRCULATIONAHA.114.009835     Document Type: Article

References (29)

1. MedSun: Newsletter 92, February 2014. http://www.accessdata.fda.gov/ scripts/cdrh/cfdocs/medsun/news/newsletter.cfm?news=92#4. Accessed February 28, 2014.
2. Lai WW, Geva T, Shirali GS, Frommelt PC, Humes RA, Brook MM, Pignatelli RH, Rychik J; Task Force of the Pediatric Council of the American Society of Echocardiography; Pediatric Council of the American Society of Echocardiography. Guidelines and standards for performance of a pediatric echocardiogram: a report from the Task Force of the Pediatric Council of the American Society of Echocardiography. J Am Soc Echocardiogr. 2006;19:1413-1430. (Pubitemid 44816413)
3. Edwards. The Aortic Valve Guide. http://ht.edwards.com/scin/edwards/ sitecollectionimages/products/heartvalves/ar05888-av-dimensions-brochure- production-brochure-pgnt.pdf. Accessed February 4, 2014.
4. Sorin Group. Mitroflow product specifications. http://www.sorin.com/ sites/default/files/roles/3/files/HV/MF-DS-specs.pdf. Accessed February 4, 2014.
5. Cohn LH, Collins JJ Jr, DiSesa VJ, Couper GS, Peigh PS, Kowalker W, Allred E. Fifteen-year experience with 1678 Hancock porcine bioprosthetic heart valve replacements. Ann Surg. 1989;210:435-442.
6. Ruel M, Kulik A, Rubens FD, Bédard P, Masters RG, Pipe AL, Mesana TG. Late incidence and determinants of reoperation in patients with prosthetic heart valves. Eur J Cardiothorac Surg. 2004;25:364-370. (Pubitemid 38340571)
7. Banbury MK, Cosgrove DM 3rd, White JA, Blackstone EH, Frater RW, Okies JE. Age and valve size effect on the long-term durability of the Carpentier-Edwards aortic pericardial bioprosthesis. Ann Thorac Surg. 2001;72:753-757. (Pubitemid 32846222)
8. Pomar JL, Jamieson WR, Pelletier LC, Gerein AN, Castellá M, Brownlee RT. Mitroflow pericardial bioprosthesis: clinical performance to ten years. Ann Thorac Surg. 1995;60(suppl):S305-S309.
9. Minami K, Zittermann A, Schulte-Eistrup S, Koertke H, Körfer R. Mitroflow synergy prostheses for aortic valve replacement: 19 years experience with 1,516 patients. Ann Thorac Surg. 2005;80:1699-1705. (Pubitemid 41464286)
10. Kopf GS, Geha AS, Hellenbrand WE, Kleinman CS. Fate of left-sided cardiac bioprosthesis valves in children. Arch Surg. 1986;121:488-490. (Pubitemid 16075710)
11. Sanders SP, Levy RJ, Freed MD, Norwood WI, Castaneda AR. Use of Hancock porcine xenografts in children and adolescents. Am J Cardiol. 1980;46:429-438. (Pubitemid 10059393)
12. Alsoufi B, Manlhiot C, McCrindle BW, Canver CC, Sallehuddin A, Al-Oufi S, Joufan M, Al-Halees Z. Aortic and mitral valve replacement in children: is there any role for biologic and bioprosthetic substitutes? Eur J Cardiothorac Surg. 2009;36:84-90.
13. Brown JM, O'Brien SM, Wu C, Sikora JA, Griffith BP, Gammie JS. Isolated aortic valve replacement in North America comprising 108,687 patients in 10 years: changes in risks, valve types, and outcomes in the Society of Thoracic Surgeons National Database. J Thorac Cardiovasc Surg. 2009;137:82-90.
14. Chikwe J, Filsoufi F. Durability of tissue valves. Semin Thorac Cardiovasc Surg. 2011;23:18-23.
15. Tan Tanny SP, Yong MS, d'Udekem Y, Kowalski R, Wheaton G, D'Orsogna L, Galati JC, Brizard CP, Konstantinov IE. Ross procedure in children: 17-year experience at a single institution. J Am Heart Assoc. 2013;2:e000153.
16. Charitos EI, Takkenberg JJ, Hanke T, Gorski A, Botha C, Franke U, Dodge-Khatami A, Hoerer J, Lange R, Moritz A, Ferrari-Kuehne K, Hetzer R, Huebler M, Bogers AJ, Stierle U, Sievers HH, Hemmer W. Reoperations on the pulmonary autograft and pulmonary homograft after the Ross procedure: an update on the German Dutch Ross Registry. J Thorac Cardiovasc Surg. 2012;144:813-821.
17. Batlivala SP, Emani S, Mayer JE, McElhinney DB. Pulmonary valve replacement function in adolescents: a comparison of bioprosthetic valves and homograft conduits. Ann Thorac Surg. 2012;93:2007-2016.
18. Jang W, Kim YJ, Choi K, Lim HG, Kim WH, Lee Jr. Mid-term results of bioprosthetic pulmonary valve replacement in pulmonary regurgitation after tetralogy of Fallot repair. Eur J Cardiothorac Surg. 2012;42:e1-e8.
19. Dvir D, Webb J, Brecker S, Bleiziffer S, Hildick-Smith D, Colombo A, Descoutures F, Hengstenberg C, Moat NE, Bekeredjian R, Napodano M, Testa L, Lefevre T, Guetta V, Nissen H, Hernández JM, Roy D, Teles RC, Segev A, Dumonteil N, Fiorina C, Gotzmann M, Tchetche D, Abdel-Wahab M, De Marco F, Baumbach A, Laborde JC, Kornowski R. Transcatheter aortic valve replacement for degenerative bioprosthetic surgical valves: results from the Global Valve-In-Valve Registry. Circulation. 2012;126:2335-2344.
20. Milburn K, Bapat V, Thomas M. Valve-in-valve implantations: is this the new standard for degenerated bioprostheses? Review of the literature [published online ahead of print January 21, 2014]. Clin Res Cardiol. doi:10.1007/s00392- 013-0653-3. http://link.springer.com/article/10.1007%2Fs00392-013-0653-3.
21. Flameng W, Rega F, Vercalsteren M, Herijgers P, Meuris B. Antimineralization treatment and patient-prosthesis mismatch are major determinants of the onset and incidence of structural valve degeneration in bioprosthetic heart valves. J Thorac Cardiovasc Surg. 2014;147:1219-1224.
22. Grunkemeier GL, Li HH, Naftel DC, Starr A, Rahimtoola SH. Durability of tissue valves. Curr Probl Cardiol. 2000;25:73-154.
23. Biglioli P, Spampinato N, Cannata A, Musumeci A, Parolari A, Gagliardi C, Alamanni F. Long-term outcomes of the Carpentier-Edwards pericardial valve prosthesis in the aortic position: effect of patient age. J Heart Valve Dis. 2004;13(suppl 1):S49-S51.
24. Pomar JL1, Jamieson WR, Pelletier LC, Castellá M, Germann E, Brownlee RT. Mitroflow pericardial bioprosthesis experience in aortic valve replacement ≥ 60 years of age. Ann Thorac Surg. 1998;66:S53-S56. (Pubitemid 29087130)
25. Yankah CA, Pasic M, Musci M, Stein J, Detschades C, Siniawski H, Hetzer R. Aortic valve replacement with the Mitroflow pericardial bioprosthesis: durability results up to 21 years. J Thorac Cardiovasc Surg. 2008;136:688-696.
26. Karamlou T, Jang K, Williams WG, Caldarone CA, Van Arsdell G, Coles JG, McCrindle BW. Outcomes and associated risk factors for aortic valve replacement in 160 children: a competing-risks analysis. Circulation. 2005;112:3462-3469. (Pubitemid 43739562)
27. Butany J, Feng T, Luk A, Law K, Suri R, Nair V. Modes of failure in explanted mitroflow pericardial valves. Ann Thorac Surg. 2011;92:1621-1627.
28. Alvarez JR, Sierra J, Vega M, Adrio B, Martinez-Comendador J, Gude F, Martinez-Cereijo J, Garcia J. Early calcification of the aortic Mitroflow pericardial bioprosthesis in the elderly. Interact Cardiovasc Thorac Surg. 2009;9:842-846.
29. US Food and Drug Administration. Medical devices. http://www.fda.gov/ MedicalDevices/DeviceRegulationandGuidance/GuidanceDocuments/ucm339162.htm#4. Accessed February 16, 2014.